Table 2

Questionnaire responses for pre-operative and intra-operative components of ERAS gynecologic oncology guidelines

ERAS elementn=454%
Pre-operative fasting solids
 6 hours286.2
 6–8 hours24754.4
 >8 hours17739.0
 Missing20.4
Pre-operative fasting liquids
 2 hours235.1
 2–6 hours26257.7
 >6 hours16736.8
 Missing20.4
Carbohydrate loading pre-operatively
 Yes16536.3
 No28262.1
 Missing71.5
Pre-operative and intra-operative DVT prophylaxis
 Yes36480.2
 No8418.5
 Maybe30.7
 Missing30.7
Intra-operative fluid management protocol
 Yes, at discretion of anesthesia team24554.0
 Yes, goal-directed therapy protocol – invasive (ie, esophageal Doppler)132.9
 Yes, goal-directed therapy protocol – non-invasive monitoring (ie, blood pressure, urinary output)8218.1
 No7316.1
 Not sure347.5
 Missing71.5
Core temperature measured in operating theater
 Yes25656.4
 No13730.2
 Unsure4910.8
 Maybe10.2
 Missing112.4
Bowel preparation use (sometimes−always)*
 For laparotomy28863.2
 Planned ovarian cancer debulking33373.3
 Concern for potential bowel surgery36279.7
Bowel preparation use (type)*
 Mechanical22048.5
 Antibiotics12327.1
 Enema23251.1
 Other5512.1
Pre-operative and intra-operative DVT prophylaxis*
 Unfractionated heparin408.8
 Low molecular weight heparin31970.3
 Stockings20745.6
 Pneumatic compression device18139.9
 Others51.1
 None367.9
Regional pain management (sometimes–always use)*
 Thoracic epidural analgesia34074.9
 Transversus abdominis plane (TAP) block21747.8

  • *Respondents had the option to choose more than one response thus % may exceed 100.

  • DVT, deep vein thrombosis; ERAS, Enhanced Recovery After Surgery.